# Linezolid

## Zyvox inj 600mg-300mL

_藥物代碼_：IZYV

_給藥途徑_：I

_用法用量_：

Dosing: dosage adjustment not necessary when switching from intravenous to oral formulation Adult: Bacteremia associated with intravascular line, Confirmed ampicillin- and vancomycin-resistant Enterococcus faecalis/faecium: \(due to ampicillin- and vancomycin-resistant Enterococcus faecalis/faecium\) 600 mg IV every 12 hours; Community acquired pneumonia: 600 mg IV or ORALLY every 12 hours for 10 to 14 days \(manufacturer dosing\) or for 7 to 21 days when MRSA-associated infection \(guideline dosing\);Infection of bone - Infectious disorder of joint: \(MRSA-associated\) 600 mg IV or ORALLY every 12 hours for a minimum of 8 weeks for osteomyelitis and 3 to 4 weeks for septic arthritis; Infection of skin AND/OR subcutaneous tissue, Complicated: 600 mg IV or ORALLY every 12 hours for 10 to 14 days \(manufacturer dosing\) or for 7 to 14 days when MRSA-associated infection \(guideline dosing\) Pediatric: Community acquired pneumonia: \(12 years and older\) 600 mg IV or ORALLY every 12 hours for 10 to 14 days Community acquired pneumonia: \(birth through 11 years of age\) 10 mg/kg IV or ORALLY every 8 hours for 10 to 14 days, not to exceed 600 mg/dose Community acquired pneumonia: \(preterm neonates less than 34 weeks gestation\) 10 mg/kg IV or ORALLY every 12 hours, increase to 10 mg/kg IV or ORALLY every 8 hours by 7 days of life or sooner for suboptimal clinical response; recommended duration of treatment, 10 to 14 days

**\***NEONATE ANTIBIOTICS DOSE**\*** Linezolid:  
Oral, IV. Bacteremia, community/ hospital-acquired pneumonia, skin infections. Vancomycin-resistant Enterococcus faecium \(VREF\) infection GA &lt;34 week Postnatal 0-7 days, dose: 10mg/kg Q12H GA =8 days, dose: 10mg/kg Q8H GA 33-44 week Postnatal 0-28 days, dose: 10mg/kg Q8H

## Zyvox 600mg

_藥物代碼_：OZYV

_給藥途徑_：O

_用法用量_：

May be taken with or without food

MRSA: 600 mg 12 hr daily 10-14 days Vancomycin-resistant Enterococcus faecium inf. 600 mg IV or orally every 12 hr for 14-28 days. Nosocomial & community-acquired pneumonia, complicated skin & skin structure infection: 600 mg IV or orally every 12 hr for 10-14 days. Uncomplicated skin & skin structure infection: 400 mg orally every 12 hr for 10-14 days. Premature or neonate &lt; 7 days 10 mg/kg/dose 12 hrly. Premature or neonate &gt; 7 days-11 year 10 mg/kg/dose 8 hrly.

